Skip to main content

Conference Highlights ASH

Chemoimmunotherapy with Fludarabine, Cyclophosphamide, and Rituximab versus Bendamustine and Rituximab in Previously Untreated and Physically Fit Patients with Advanced Chronic Lymphocytic Leukemia

Safety and Efficacy of Obinutuzumab (GA101) with Fludarabine Cyclophosphamide or Bendamustine in the Initial Therapy of Patients with Chronic Lymphocytic Leukemia: Results from the Phase 1b GALTON Trial

Chronic Lymphocytic Leukemia: A New Treatment Era is Born

Head-To-Head Comparison of Obinutuzumab Plus Chlorambucil versus Rituximab Plus Chlorambucil in Patients with Chronic Lymphocytic Leukemia and Coexisting Medical Conditions: Final Stage 2 Results of the CLL11 Trial

Siltuximab: Monoclonal Antibody Relieves Symptoms of Castleman’s Disease

More Transplants Made Possible Through Haploidentical Donors

Caroline Helwick

Hospital Readmission After Stem-Cell Transplant Decreases Survival

JAK1/2 Inhibitor Ruxolitinib Improves Survival in High-Risk Myelofibrosis

Ready-Made Platelets? A Boon for Patients If It Works

Neil Canavan, Neil Canavan

High Morbidity Burden Borne Years Later by Survivors of Transplant

Caroline Helwick, Caroline Helwick

1
2
3
4

Page 3 of 4
Results 21 - 30 of 35